Article
Novel humanized monoclonal antibodies against ROR1 for cancer therapy
13 Aug 2024
Abstract excerpt
BACKGROUND: Overexpression of receptor tyrosine kinase-like orphan receptor 1 (ROR1) contributes to cancer cell proliferation, survival and migration, playing crucial roles in tumor development. ROR1 has been proposed as a potential therapeutic target for cancer treatment. This study aimed to develop novel humanized ROR1 monoclonal antibodies and investigate their anti-tumor effects. METHODS: ROR1 expression in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
